Literature DB >> 21329846

Antiarrhythmic effects of simvastatin in canine pulmonary vein sleeve preparations.

Serge Sicouri1, Brittany Gianetti, Andrew C Zygmunt, Jonathan M Cordeiro, Charles Antzelevitch.   

Abstract

OBJECTIVES: The purpose of this study was to determine the electrophysiologic effects of simvastatin in canine pulmonary vein (PV) sleeve preparations.
BACKGROUND: Ectopic activity arising from the PV plays a prominent role in the development of atrial fibrillation.
METHODS: Transmembrane action potentials were recorded from canine superfused left superior or inferior PV sleeves using standard microelectrode techniques. Acetylcholine (1 μM), isoproterenol (1 μM), high calcium ([Ca(2+)](o) = 5.4 mM), or a combination was used to induce early afterdepolarizations or delayed afterdepolarizations and triggered activity. Voltage clamp experiments were performed in the left atrium measuring fast and late sodium currents.
RESULTS: Under steady-state conditions, simvastatin (10 nM, n = 9) induced a small increase in action potential duration measured at 85% repolarization and a significant decrease in action potential amplitude, take-off potential, and maximum rate of rise of action potential upstroke at the fastest rates. The V(max) decreased from 175.1 ± 34 V/s to 151.7 ± 28 V/s and from 142 ± 47 V/s to 97.4 ± 39 V/s at basic cycle lengths of 300 and 200 ms, respectively. Simvastatin (10 to 20 nM) eliminated delayed afterdepolarizations and delayed afterdepolarization-induced triggered activity in 7 of 7 PV sleeve preparations and eliminated or reduced late-phase 3 early afterdepolarizations in 6 of 6 PV sleeve preparations. Simvastatin (20 nM) did not affect late or fast sodium currents measured using voltage clamp techniques.
CONCLUSIONS: Our data suggest that in addition to its upstream actions to reduce atrial structural remodeling, simvastatin exerts a direct antiarrhythmic effect by suppressing triggers responsible for the genesis of atrial fibrillation.
Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21329846      PMCID: PMC3058742          DOI: 10.1016/j.jacc.2010.08.649

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  39 in total

1.  Spotlight on atrial fibrillation-the 'complete arrhythmia'.

Authors:  Stanley Nattel; Maurits Allessie; Michel Haissaguerre
Journal:  Cardiovasc Res       Date:  2002-05       Impact factor: 10.787

2.  Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci.

Authors:  M Haïssaguerre; P Jaïs; D C Shah; S Garrigue; A Takahashi; T Lavergne; M Hocini; J T Peng; R Roudaut; J Clémenty
Journal:  Circulation       Date:  2000-03-28       Impact factor: 29.690

3.  Arrhythmogenic activity of cardiac muscle in pulmonary veins of the dog: implication for the genesis of atrial fibrillation.

Authors:  Y J Chen; S A Chen; M S Chang; C I Lin
Journal:  Cardiovasc Res       Date:  2000-11       Impact factor: 10.787

4.  Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance.

Authors:  O Feron; C Dessy; J P Desager; J L Balligand
Journal:  Circulation       Date:  2001-01-02       Impact factor: 29.690

5.  Larger late sodium conductance in M cells contributes to electrical heterogeneity in canine ventricle.

Authors:  A C Zygmunt; G T Eddlestone; G P Thomas; V V Nesterenko; C Antzelevitch
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-08       Impact factor: 4.733

6.  Antiarrhythmic effects of losartan and enalapril in canine pulmonary vein sleeve preparations.

Authors:  Serge Sicouri; Jonathan M Cordeiro; Michael Talarico; Charles Antzelevitch
Journal:  J Cardiovasc Electrophysiol       Date:  2010-12-16

7.  Simvastatin modulates cytokine-mediated endothelial cell adhesion molecule induction: involvement of an inhibitory G protein.

Authors:  M M Sadeghi; M Collinge; R Pardi; J R Bender
Journal:  J Immunol       Date:  2000-09-01       Impact factor: 5.422

8.  Electrical conduction in canine pulmonary veins: electrophysiological and anatomic correlation.

Authors:  Mélèze Hocini; Siew Y Ho; Tokuhiro Kawara; André C Linnenbank; Mark Potse; Dipen Shah; Pierre Jaïs; Michiel J Janse; Michel Haïssaguerre; Jacques M T De Bakker
Journal:  Circulation       Date:  2002-05-21       Impact factor: 29.690

Review 9.  Mechanisms of termination of atrial fibrillation by Class I antiarrhythmic drugs: evidence from clinical, experimental, and mathematical modeling studies.

Authors:  Stanley Nattel; James Kneller; Renqiang Zou; L Joshua Leon
Journal:  J Cardiovasc Electrophysiol       Date:  2003-10

10.  Reinduction of atrial fibrillation immediately after termination of the arrhythmia is mediated by late phase 3 early afterdepolarization-induced triggered activity.

Authors:  Alexander Burashnikov; Charles Antzelevitch
Journal:  Circulation       Date:  2003-04-14       Impact factor: 29.690

View more
  9 in total

1.  Electrophysiological characteristics of canine superior vena cava sleeve preparations: effect of ranolazine.

Authors:  Serge Sicouri; Jonathan Blazek; Luiz Belardinelli; Charles Antzelevitch
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-03-09

2.  Comparison of electrophysiological and antiarrhythmic effects of vernakalant, ranolazine, and sotalol in canine pulmonary vein sleeve preparations.

Authors:  Serge Sicouri; Marc Pourrier; John K Gibson; Joseph J Lynch; Charles Antzelevitch
Journal:  Heart Rhythm       Date:  2011-10-20       Impact factor: 6.343

Review 3.  Novel pharmacological targets for the rhythm control management of atrial fibrillation.

Authors:  Alexander Burashnikov; Charles Antzelevitch
Journal:  Pharmacol Ther       Date:  2011-08-17       Impact factor: 12.310

4.  Statin use and postoperative atrial fibrillation after major noncardiac surgery.

Authors:  Prashant D Bhave; L Elizabeth Goldman; Eric Vittinghoff; Judith H Maselli; Andrew Auerbach
Journal:  Heart Rhythm       Date:  2011-09-09       Impact factor: 6.343

5.  Influence of ischemic core muscle fibers on surface depolarization potentials in superfused cardiac tissue preparations: a simulation study.

Authors:  Fernando O Campos; Anton J Prassl; Gunnar Seemann; Rodrigo Weber dos Santos; Gernot Plank; Ernst Hofer
Journal:  Med Biol Eng Comput       Date:  2012-03-13       Impact factor: 2.602

6.  Attenuation of acetylcholine activated potassium current (I KACh) by simvastatin, not pravastatin in mouse atrial cardiomyocyte: possible atrial fibrillation preventing effects of statin.

Authors:  Kyoung-Im Cho; Tae-Joon Cha; Su-Jin Lee; In-Kyeung Shim; Yin Hua Zhang; Jung-Ho Heo; Hyun-Su Kim; Sung Joon Kim; Kyoung-Lyoung Kim; Jae-Woo Lee
Journal:  PLoS One       Date:  2014-10-16       Impact factor: 3.240

Review 7.  Addressing Extracardiac Risk Factors to Improve Atrial Fibrillation Treatment Outcomes.

Authors:  Jason G Andrade; Laurent Macle
Journal:  J Innov Card Rhythm Manag       Date:  2019-11-15

8.  Perioperative Statin Use May Reduce Postoperative Arrhythmia Rates After Total Joint Arthroplasty.

Authors:  John C Bonano; Ashley K Aratani; Tanmaya D Sambare; Stuart B Goodman; James I Huddleston; William J Maloney; David R Burk; Alistair J Aaronson; Andrea K Finlay; Derek F Amanatullah
Journal:  J Arthroplasty       Date:  2021-05-25       Impact factor: 4.757

9.  Routine versus aggressive upstream rhythm control for prevention of early atrial fibrillation in heart failure: background, aims and design of the RACE 3 study.

Authors:  M Alings; M D Smit; M L Moes; H J G M Crijns; J G P Tijssen; J Brügemann; H L Hillege; D A Lane; G Y H Lip; J R L M Smeets; R G Tieleman; R Tukkie; F F Willems; R A Vermond; D J Van Veldhuisen; I C Van Gelder
Journal:  Neth Heart J       Date:  2013-07       Impact factor: 2.380

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.